Advances in sonoporation strategies for cancer

Olga Cain, Marxa L. Figueiredo

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We will focus on the therapeutic applications of ultrasound (US) for gene transfection or 'sonoporation'. Sonoporation therapy or 'sonotherapy' is an emerging physical method for delivering drugs and/or nucleic acids for treating cancer. Because of its non-invasive nature, sonotherapy has the potential to be competitive with other treatment delivery methods such as viruses or lipofection. For nucleic acid delivery, sonoporation in the presence of microbubbles (MB) significantly enhances transfection efficiency. Sonoporation is an ideal means of delivering pDNA, and it has a similar efficiency as electroporation or other physical gene therapy techniques, with potentially fewer side effects. Typically, nonphysical means of gene delivery have suffered from lower efficiencies compared to viral vectors, however, several studies suggest that sonoporation pDNA delivery could be a simple and inexpensive method that only requires a plasmid, MB, and a sonoporation device. Sonoporation could also be used to target MB to certain cells/tissues, delivering localized therapies. Using high-performance probes, more precise and safer sonoporation treatments will be developed, and newer therapeutic prospects will be realized.

Original languageEnglish (US)
Pages (from-to)988-1006
Number of pages19
JournalFrontiers in Bioscience - Scholar
Volume4 S
Issue number3
StatePublished - Jan 1 2012

Fingerprint

Microbubbles
Nucleic Acids
Genes
Gene therapy
Neoplasms
Viruses
Transfection
Plasmids
Therapeutics
Physical Therapy Modalities
Ultrasonics
Tissue
Electroporation
Pharmaceutical Preparations
Genetic Therapy
Equipment and Supplies

Keywords

  • Cancer
  • Gene delivery
  • Gene therapy
  • Microbubbles
  • Review
  • Sonoporation
  • Sonotherapy
  • Ultrasound

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Cain, O., & Figueiredo, M. L. (2012). Advances in sonoporation strategies for cancer. Frontiers in Bioscience - Scholar, 4 S(3), 988-1006.

Advances in sonoporation strategies for cancer. / Cain, Olga; Figueiredo, Marxa L.

In: Frontiers in Bioscience - Scholar, Vol. 4 S, No. 3, 01.01.2012, p. 988-1006.

Research output: Contribution to journalArticle

Cain, O & Figueiredo, ML 2012, 'Advances in sonoporation strategies for cancer', Frontiers in Bioscience - Scholar, vol. 4 S, no. 3, pp. 988-1006.
Cain O, Figueiredo ML. Advances in sonoporation strategies for cancer. Frontiers in Bioscience - Scholar. 2012 Jan 1;4 S(3):988-1006.
Cain, Olga ; Figueiredo, Marxa L. / Advances in sonoporation strategies for cancer. In: Frontiers in Bioscience - Scholar. 2012 ; Vol. 4 S, No. 3. pp. 988-1006.
@article{82fbc4e0f81d44a9bd102c961e6875b8,
title = "Advances in sonoporation strategies for cancer",
abstract = "We will focus on the therapeutic applications of ultrasound (US) for gene transfection or 'sonoporation'. Sonoporation therapy or 'sonotherapy' is an emerging physical method for delivering drugs and/or nucleic acids for treating cancer. Because of its non-invasive nature, sonotherapy has the potential to be competitive with other treatment delivery methods such as viruses or lipofection. For nucleic acid delivery, sonoporation in the presence of microbubbles (MB) significantly enhances transfection efficiency. Sonoporation is an ideal means of delivering pDNA, and it has a similar efficiency as electroporation or other physical gene therapy techniques, with potentially fewer side effects. Typically, nonphysical means of gene delivery have suffered from lower efficiencies compared to viral vectors, however, several studies suggest that sonoporation pDNA delivery could be a simple and inexpensive method that only requires a plasmid, MB, and a sonoporation device. Sonoporation could also be used to target MB to certain cells/tissues, delivering localized therapies. Using high-performance probes, more precise and safer sonoporation treatments will be developed, and newer therapeutic prospects will be realized.",
keywords = "Cancer, Gene delivery, Gene therapy, Microbubbles, Review, Sonoporation, Sonotherapy, Ultrasound",
author = "Olga Cain and Figueiredo, {Marxa L.}",
year = "2012",
month = "1",
day = "1",
language = "English (US)",
volume = "4 S",
pages = "988--1006",
journal = "Frontiers in Bioscience - Scholar",
issn = "1945-0516",
publisher = "Frontiers in Bioscience",
number = "3",

}

TY - JOUR

T1 - Advances in sonoporation strategies for cancer

AU - Cain, Olga

AU - Figueiredo, Marxa L.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - We will focus on the therapeutic applications of ultrasound (US) for gene transfection or 'sonoporation'. Sonoporation therapy or 'sonotherapy' is an emerging physical method for delivering drugs and/or nucleic acids for treating cancer. Because of its non-invasive nature, sonotherapy has the potential to be competitive with other treatment delivery methods such as viruses or lipofection. For nucleic acid delivery, sonoporation in the presence of microbubbles (MB) significantly enhances transfection efficiency. Sonoporation is an ideal means of delivering pDNA, and it has a similar efficiency as electroporation or other physical gene therapy techniques, with potentially fewer side effects. Typically, nonphysical means of gene delivery have suffered from lower efficiencies compared to viral vectors, however, several studies suggest that sonoporation pDNA delivery could be a simple and inexpensive method that only requires a plasmid, MB, and a sonoporation device. Sonoporation could also be used to target MB to certain cells/tissues, delivering localized therapies. Using high-performance probes, more precise and safer sonoporation treatments will be developed, and newer therapeutic prospects will be realized.

AB - We will focus on the therapeutic applications of ultrasound (US) for gene transfection or 'sonoporation'. Sonoporation therapy or 'sonotherapy' is an emerging physical method for delivering drugs and/or nucleic acids for treating cancer. Because of its non-invasive nature, sonotherapy has the potential to be competitive with other treatment delivery methods such as viruses or lipofection. For nucleic acid delivery, sonoporation in the presence of microbubbles (MB) significantly enhances transfection efficiency. Sonoporation is an ideal means of delivering pDNA, and it has a similar efficiency as electroporation or other physical gene therapy techniques, with potentially fewer side effects. Typically, nonphysical means of gene delivery have suffered from lower efficiencies compared to viral vectors, however, several studies suggest that sonoporation pDNA delivery could be a simple and inexpensive method that only requires a plasmid, MB, and a sonoporation device. Sonoporation could also be used to target MB to certain cells/tissues, delivering localized therapies. Using high-performance probes, more precise and safer sonoporation treatments will be developed, and newer therapeutic prospects will be realized.

KW - Cancer

KW - Gene delivery

KW - Gene therapy

KW - Microbubbles

KW - Review

KW - Sonoporation

KW - Sonotherapy

KW - Ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84869437865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869437865&partnerID=8YFLogxK

M3 - Article

C2 - 22202104

AN - SCOPUS:84869437865

VL - 4 S

SP - 988

EP - 1006

JO - Frontiers in Bioscience - Scholar

JF - Frontiers in Bioscience - Scholar

SN - 1945-0516

IS - 3

ER -